The impact of a nurse-led care programme on events and physical and psychosocial parameters in patients with heart failure with preserved ejection fraction: A randomized clinical trial in primary care in Russia

European Journal of General Practice

Volumn 16, Issue 4, 2010, Pages 205-214

  Andryukhin, Anton ^a   Frolova, Elena ^a   Vaes, Bert ^c   Degryse, Jan ^b,c  

^a NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Congestive heart failure; Disease management programme; Heart failure with preserved systolic function; Nurse led care; Primary care

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANXIETY; ARTICLE; BODY MASS; BODY WEIGHT; BREATHING EXERCISE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EMOTION; EXERCISE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GENERAL PRACTICE; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH PROGRAM; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HOSPITALIZATION; HUMAN; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NURSE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PHYSICAL PARAMETERS; PRIMARY MEDICAL CARE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RUSSIAN FEDERATION; WAIST CIRCUMFERENCE; WALKING;

AGED; BODY WEIGHT; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; EXERCISE; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HEART FAILURE; HUMANS; LIFE STYLE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NURSE'S PRACTICE PATTERNS; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; RISK REDUCTION BEHAVIOR; RUSSIA; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 78649312161     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.3109/13814788.2010.527938     Document Type: Article

References (34)

1. Mareev VIu, Danielyan MO, Belenkov IuN. Comparative characteristics of patients with CHF in relation to the value of injection fraction by data from the Russian multicenter study EPOCH-A-CHF: Once more about the problem of CHF with preserved left ventricular systolic function. J Heart Fail. 2006;4:164-71.
2. Gustafsson F, Malcolm J, Arnold O. Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J. 2004;25:1596-604.
3. Rumsfeld JS, Masoudi FA. Heart failure disease management works, but will it succeed? Eur Heart J. 2004;25:1565-7.
4. Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Ar-talejo F. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: A systematic review and meta-analysis of published reports. Eur Heart J. 2004;25:1570-95.
5. Ageev FT, Mareev VIu, Seredenina EM, Belenkov IuN. Prospects of introduction of specialised forms of active outpatient conducting patients with heart failure: A structure, a technique and preliminary results of the Russian program 'SHANS.' J Heart Fail. 2004;5:268-71.
6. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46.
7. Aurigemma GP, Gaasch WH. Diastolic heart failure. N Engl J Med. 2004;351:1097-105.
8. Tribouilloy Ch, Rusinaru D, Mahjoub H, Soulière V, Lévy F, Peltier M, et al. Prognosis of heart failure with preserved ejection fraction: A five-year prospective population-based study. Eur Heart J. 2008;29:339-47.
9. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355:251-9.
10. Eichhorn EJ. Prognosis determination in heart failure. Am J Med. 2001;110(Suppl. 7A):14S-36S.
11. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction: Mortality, readmission, and functional decline. Am Coll Cardiol. 2003;41:1510-8.
12. Smith B, Forkner E, Zaslow B, Krasuski RA, Stajduhar K, Kwan M, et al. Disease management produces limited quality of life improvements in patients with congestive heart failure: Evidence from a randomized trial in community-dwelling patients. Am J Manag Care 2005;11:701-13.
13. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26: 1115-40.
14. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease: Executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
15. National Recommendations of Russian Academic Society of Cardiology and the Society of Specialists in Heart Failure regarding diagnosis and treatment of congestive HF- Second Review. J Heart Fail. 2006;8:1-35.
16. Kubzansky LD, Kawachi I, Weiss ST, Sparrow D. Anxiety and coronary heart disease: A synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med. 1998;20:47-58.
17. Zigmond AS, Snaith R P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.
18. Riegel B, Moser DK, Glaser D, Carlson B, Deaton C, Armola R, et al. The Minnesota living with heart failure questionnaire: Sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nursing Res. 2002;51:209-18.
19. Speer DC, Greenbaum PE. Five methods for computing sig-nificant individual client change and improvement rates: Support for an individual growth curve approach. J Consult Clin Psychol. 1995;63:1044-8.
20. Gary RA, Sueta CA, Dougherty M, Rosenberg B, Cheek D, Preisser J, et al. Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung 2004;33:210-8.
21. Galbreath AD, Krasuski RA, Smith B, Stajduhar K, Kwan M, Ellis R, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004;110: 3518-26.
22. Bruggink-Andre de la Porte PWF, Lok DJA, Van Veldhuisen DJ, Van Wijngaarden J, Cornel JH, Zuithoff NPA, et al. Added value of a physician-and-nurse-directed heart failure clinic: Results from the Deventer-Alkmaar heart failure study. Heart 2007;93:819-25.
23. Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, Swedberg K, et al. Differences between patients with a preserved and a depressed left ventricular function: A report from the EuroHeart Failure Survey. Eur Heart J. 2004;25:1214-20.
24. Wal Van Der MH, Jaarsma T, Van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail. 2005;7:5-17.
25. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary: The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26: 1115-30.
26. Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, et al. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: Favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Eur J Car-diovasc Prev Rehabil. 2008;15:113-8.
27. Reisfield GM, Wilson GR. Prognostication in heart failure. J Palliat Med. 2007;10:245-6.
28. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burrel G, Ciffkova R et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375-414.
29. Crapo RO, Casaburi R, Coates AL, Enright PL, MacIntyre NR, McKay RT, et al. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166:1111-7.
30. Pearson TA, Mensah GA, Wayne AR, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and American Heart Association. Circulation 2003;107:499-511.
31. Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol. 2008;102:469-74.
32. Vazquez R, Bayes-Genis A, Cygankiewicz I, Pascual-Figal D, Grigorian-Shamagian L, Pavon R, et al. The MUSIC Risk score: A simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J. 2009;30: 1088-96.
33. Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J, et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: The Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol. 2005;45:1064-71.
34. Khouri SJ, Maly GT, Suh DD, Walsh TE. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr. 2004;17:290-7.